Dear Sir, Please find newspaper Advertisement of Unaudited Financial Results of Omkar for the Quarter ended June 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Omkar Pharmachem has published its standalone unaudited financial results for the quarter ended 30 June 2025 in newspapers, as required under SEBI LODR Regulation 47. Total income from operations for the quarter stood at Rs. 13.50 crore (Rs. 1,350 lakh). Net profit before tax was Rs. 3.58 crore and profit after tax came in at Rs. 2.66 crore, with basic and diluted EPS of Rs. 0.0264. The results were reviewed by the audit committee and approved by the board on 13 August 2025, and have undergone a limited review by the statutory auditors. Other equity stands in negative territory at Rs. (65.00) lakh, indicating accumulated losses.
This is a routine regulatory newspaper publication of already-filed quarterly results, so no new fundamental information is being shared with the market. The negative other equity is a flag worth noting for shareholders as it points to past accumulated losses, though the company continues to report a quarterly profit.